心臟植入市場規模、佔有率和成長分析（按設備類型、應用、最終用戶和地區）- 行業預測，2025 年至 2032 年

全球心臟植入市場預計將在 2023 年達到 161 億美元，並從 2024 年的 171.1 億美元成長到 2032 年的 279 億美元，預測期內（2025-2032 年）的複合年成長率為 6.3%。

由於心血管疾病發病率上升、技術進步和人口老化，全球心臟植入市場正在經歷強勁成長。久坐的生活方式和肥胖、糖尿病等健康問題日益嚴重，推動了對心臟植入的需求，心臟植入物被認為是改善患者生活品質的重要治療選擇。小型化和無線連接等技術進步使得心律調節器和心臟去顫器等設備更加高效且更易於使用。然而，市場面臨的挑戰包括高成本限制了低收入地區的可用性，嚴格的監管障礙減緩了新產品的推出，以及對長期性能和潛在併發症的擔憂。應對這些挑戰對於促進心臟植入領域的創新和確保病患安全至關重要。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和資料資料
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

心臟植入市場規模（按設備類型和複合年成長率） (2025-2032)

• 市場概況
• 心律調節器裝置
• 心臟再同步治療裝置
• 植入式血流動力學監測裝置
• 植入式心率監測儀
• 冠狀動脈支架
• 植入式心臟整流去顫器
• 心臟瓣膜
• 其他

心臟植入市場規模（按應用分類）及複合年成長率（2025-2032）

• 市場概況
• 心律不整
• 心肌缺血
• 急性心肌梗塞
• 鬱血性心臟衰竭
• 其他

心臟植入市場規模（按最終用戶和複合年成長率分類）（2025-2032）

• 市場概況
• 醫院
• 專科門診
• 其他

心臟植入市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較（2022-2024 年）

主要企業簡介

• Medtronic（USA）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Biotronik SE & Co. KG（Germany）
• Lepu Medical Technology Co., Ltd.（China）
• LivaNova PLC（UK）
• Osypka AG（Germany）
• Oscor Inc.（USA）
• Pacetronix（India）
• Medico SpA（Italy）
• MicroPort Scientific Corporation（China）
• Shree Pacetronix Ltd.（India）
• Biotricity Inc.（USA）
• Cardiac Science Corporation（USA）
• EBR Systems, Inc.（USA）
• Jarvik Heart, Inc.（USA）
• Berlin Heart GmbH（Germany）
• ReliantHeart Inc.（USA）
• SynCardia Systems, LLC（USA）
• BiVacor（USA）

結論和建議

Global Cardiac Implants Market size was valued at USD 16.1 billion in 2023 and is poised to grow from USD 17.11 billion in 2024 to USD 27.9 billion by 2032, growing at a CAGR of 6.3% during the forecast period (2025-2032).

The global cardiac implants market is experiencing robust growth, propelled by the rising prevalence of cardiovascular diseases, technological innovations, and an aging demographic. Increasing sedentary lifestyles and health issues, such as obesity and diabetes, are heightening the demand for cardiac implants, which are viewed as vital treatment options to enhance patient quality of life. Technological advancements, including miniaturization and wireless connectivity, are improving the efficiency and user-friendliness of devices like pacemakers and defibrillators. However, the market faces challenges, including high costs that limit accessibility in low-income areas, stringent regulatory hurdles that can delay new product introduction, and concerns regarding long-term performance and potential complications. Addressing these challenges is essential for fostering innovation and ensuring patient safety in the cardiac implants sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Implants market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Implants Market Segmental Analysis

Global Cardiac Implants Market is segmented by Device Type, Application, End User and region. Based on Device Type, the market is segmented into Pacemaker Devices, Cardiac Resynchronization Therapy Devices, Implantable Hemodynamic Monitoring Devices, Implanted Heart Rhythm Monitors, Coronary Stents, Implantable Cardioverter Defibrillator, Heart Valve and Others. Based on Application, the market is segmented into Arrhythmias, Myocardial Ischemia, Acute Myocardial Infraction, Congestive Heart Failure and Others. Based on End User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Implants Market

One of the key factors propelling the global cardiac implants market is the escalating incidence of cardiovascular diseases, encompassing conditions such as heart failure, arrhythmias, and coronary artery disease. This rise can be attributed to various contributors, including increasingly sedentary lifestyles, poor dietary choices, and a rapidly aging population. As these factors lead to a greater prevalence of cardiovascular issues, the demand for cardiac implants intensifies, thereby driving market growth. The urgent need for effective treatment options to manage these conditions highlights the significance of the cardiac implants sector in addressing the healthcare challenges posed by cardiovascular diseases.

Restraints in the Global Cardiac Implants Market

One of the significant challenges facing the global cardiac implants market is the rigorous regulatory approval processes that manufacturers must navigate. Compliance with the stringent standards set by regulatory authorities, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), can often be a lengthy and expensive undertaking. This extensive vetting process can result in delays for the launch of new technologies and products, hindering innovation and stifling the overall growth of the market. As a result, these regulatory hurdles create a restrictive environment for the advancement of cardiac implant solutions.

Market Trends of the Global Cardiac Implants Market

The Global Cardiac Implants market is experiencing a notable shift towards the integration of remote monitoring and digital health solutions, reflecting a burgeoning trend in patient care. This innovation facilitates continuous oversight of patients' cardiac health and device functionality, empowering healthcare providers to deliver prompt interventions and tailored treatment plans. By leveraging these technologies, the market is not only enhancing patient management but also significantly reducing hospital readmissions, thereby improving overall healthcare efficiency. As patient-centered care gains prominence, the adoption of remote monitoring solutions is poised to reshape the cardiac implants landscape, driving growth and innovation within the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Cardiac Implants Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Pacemaker Devices
• Cardiac Resynchronization Therapy Devices
• Implantable Hemodynamic Monitoring Devices
• Implanted Heart Rhythm Monitors
• Coronary Stents
• Implantable Cardioverter Defibrillator
• Heart Valve
• Others

Global Cardiac Implants Market Size by Application & CAGR (2025-2032)

• Market Overview
• Arrhythmias
• Myocardial Ischemia
• Acute Myocardial Infraction
• Congestive Heart Failure
• Others

Global Cardiac Implants Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Specialty Clinics
• Others

Global Cardiac Implants Market Size & CAGR (2025-2032)

• North America (Device Type, Application, End User)
  • US
  • Canada
• Europe (Device Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Osypka AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oscor Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacetronix (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medico S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotricity Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Science Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EBR Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jarvik Heart, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Berlin Heart GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ReliantHeart Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SynCardia Systems, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BiVacor (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations